479074-07-2

Basic information

• Product Name: 3-(6,7-Dihydro-1-Methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride
• Synonyms: 3-(6,7-Dihydro-1-Methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride;4-Ethoxy-3-(1-methyl-3-propyl-7-thioxo-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzene-1-sulfonyl chloride
• CAS NO: 479074-07-2
• Molecular Formula: C₁₇H₁₉ClN₄O₃S₂
• Molecular Weight: 427
• Product Categories: Bases & Related Reagents;Intermediates;Nucleotides
• Mol File: 479074-07-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: Refrigerator
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 3-(6,7-Dihydro-1-Methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(6,7-Dihydro-1-Methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride(479074-07-2)
• EPA Substance Registry System: 3-(6,7-Dihydro-1-Methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride(479074-07-2)

Safety Data

• Hazardous Substances Data: 479074-07-2(Hazardous Substances Data)

Relevant articles and documents

PYRAZOLOPYRIMIDINETHIONE DERIVATIVES, SALTS AND SOLVATES THEREOF, PREPARATION METHODS AND USE THEREOF

The present invention disclosed the pyrazolopyrimidinethione derivatives, salts and solvates thereof, preparation methods and use thereof. The pyrazolopyrimidinethione derivatives according to the present invention possess the structure of general formula I , wherein, R1, R2, R3, and R4 represent alkyl, alkenyl, or aryl; R5 represents hydrogen, alkyl, alkenyl, alkoxy, cycloalkyloxy, aryl, or alkylacyl; and R6 represents hydrogen, alkyl, alkenyl, cycloalkyloxy, or alkylacyl. The pharmaceuticals containing the compound of the present invention and used for the treatment of impotence and sexlessness have the advantages of high selectivity over PDEV, long action time, and less side reactions, and the pharmaceuticals will arouse no side reactions of blood pressure decreasing and heart rate increasing, and it has broad market propect.